Saira Nisar

Saira Nisar serves as Assistant Professor in the Department of Anesthesiology at the University of Maryland School of Medicine, based at the University of Maryland Medical Center (UMMC) in clinical location S11D04. Her dual expertise spans clinical anesthesiology and critical care research with specialized focus on burn medicine.

Her academic credentials include:

• B.S. in Biological Sciences (Cell Biology and Molecular Genetics) from University of Maryland, College Park (2003-2006)
• M.S. in Biomedical Science from University of Medicine & Dentistry of New Jersey (2007-2008)
• MBBS from Norwich Medical School, University of East Anglia, UK (2009-2014)
• Post-Graduate Certificate in Health Research from University of Leeds, UK (2015-2016)

Dr. Nisar's research integrates anesthesiology with acute trauma management, particularly investigating electrical injury protocols, ultrasound-guided airway interventions for angioedema, and endothelial biomarkers in inhalation burns. Her work emphasizes evidence-based clinical algorithms for complex trauma scenarios, bridging molecular physiology with bedside critical care applications. Current investigations focus on early detection of tissue damage through novel biomarkers and point-of-care ultrasound techniques.

Recent publications (2021-2023) reveal evolving research trajectories from treatment algorithm validation toward physiological biomarker discovery. Key thematic developments include: transition from clinical protocol implementation (2021 electrical injury study) to diagnostic innovation (2022 ultrasound application), culminating in mechanistic exploration of endothelial damage pathways (2023 syndecan-1 research). This progression demonstrates deepening focus on physiological underpinnings of burn trauma while maintaining clinical translation priorities.

Her clinical practice at UMMC directly informs research priorities in burn critical care, with ongoing work examining physiological responses to inhalation injury and emergency airway management solutions. Current projects appear concentrated on validating non-invasive monitoring techniques and biomarker panels for early trauma assessment.